1. Home
  2. PGEN vs IHRT Comparison

PGEN vs IHRT Comparison

Compare PGEN & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.85

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

HOLD

Current Price

$2.70

Market Cap

589.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
IHRT
Founded
1998
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
589.5M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
PGEN
IHRT
Price
$6.85
$2.70
Analyst Decision
Buy
Sell
Analyst Count
5
2
Target Price
$8.33
$4.25
AVG Volume (30 Days)
4.6M
519.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.19
EPS
0.03
N/A
Revenue
$230,981,000.00
$3,864,991,000.00
Revenue This Year
$1,115.92
$9.96
Revenue Next Year
$81.04
N/A
P/E Ratio
$226.67
N/A
Revenue Growth
N/A
0.27
52 Week Low
$2.99
$2.26
52 Week High
$7.72
$6.56

Technical Indicators

Market Signals
Indicator
PGEN
IHRT
Relative Strength Index (RSI) 47.73 37.89
Support Level $6.60 $2.56
Resistance Level $7.32 $4.03
Average True Range (ATR) 0.28 0.14
MACD -0.10 0.03
Stochastic Oscillator 9.36 33.15

Price Performance

Historical Comparison
PGEN
IHRT

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: